CLDN11 and meningioma: Specifically, NF2 meningiomas expressed higher levels of arachnoid CLDN11 and pial LAMA2, while TRAF7 tumors overexpressed dural MGP and dural/arachnoid CRABP2 relative to NF2 tumors.